We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 11.48% |
| 3 | Communication Services | 7.14% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Healthcare | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBLL
2576
CeriBell Inc
CBLL
$895M
| $145K | ﹤0.01% |
+7,933
| New | +$159K |
|
2577
Forward Air
FWRD
$640M
| $144K | ﹤0.01% |
+8,616
| New | +$210K |
|
2578
Minerva Neurosciences
NERV
$219M
| $144K | ﹤0.01% |
+23,853
| New | +$137K |
|
2579
Groupon
GRPN
$875M
| $143K | ﹤0.01% |
+12,036
| New | +$161K |
|
|
CWBC
2580
Community West Bancshares
CWBC
$708M
| $142K | ﹤0.01% |
+6,096
| New | +$143K |
|
2581
Akebia Therapeutics
AKBA
$242M
| $142K | ﹤0.01% |
+102,145
| New | +$140K |
|
|
SMC
2582
Summit Midstream
SMC
$482M
| $142K | ﹤0.01% |
+4,694
| New | +$137K |
|
2583
Ibotta
IBTA
$783M
| $141K | ﹤0.01% |
+4,712
| New | +$110K |
|
|
BFS
2584
Saul Centers
BFS
$860M
| $141K | ﹤0.01% |
+4,316
| New | +$143K |
|
|
ITIC
2585
Investors Title Co
ITIC
$543M
| $140K | ﹤0.01% |
+645
| New | +$155K |
|
2586
Weave Communications
WEAV
$437M
| $139K | ﹤0.01% |
+30,072
| New | +$175K |
|
2587
Capital Bancorp
CBNK
$613M
| $139K | ﹤0.01% |
+4,671
| New | +$140K |
|
|
BLLN
2588
BillionToOne Inc
BLLN
$4.4B
| $139K | ﹤0.01% |
+1,755
| New | +$144K |
|
2589
Lightbridge
LTBR
$317M
| $138K | ﹤0.01% |
+12,970
| New | +$180K |
|
2590
Atea Pharmaceuticals
AVIR
$411M
| $138K | ﹤0.01% |
+25,681
| New | +$118K |
|
2591
Conduent
CNDT
$236M
| $138K | ﹤0.01% |
+107,750
| New | +$164K |
|
|
ONTF
2592
DELISTED
ON24
ONTF
| $138K | ﹤0.01% |
+16,987
| New | +$136K |
|
2593
Shinhan Financial Group
SHG
$35.4B
| $137K | ﹤0.01% |
+2,238
| New | +$137K |
|
2594
Fulgent Genetics
FLGT
$511M
| $137K | ﹤0.01% |
+8,602
| New | +$187K |
|
2595
Zymeworks
ZYME
$1.78B
| $137K | ﹤0.01% |
+5,459
| New | +$129K |
|
2596
Plumas Bancorp
PLBC
$439M
| $136K | ﹤0.01% |
+2,793
| New | +$138K |
|
2597
IMAX
IMAX
$2.9B
| $136K | ﹤0.01% |
+3,584
| New | +$133K |
|
2598
X4 Pharmaceuticals
XFOR
$418M
| $136K | ﹤0.01% |
+32,977
| New | +$124K |
|
2599
Ring Energy
REI
$357M
| $136K | ﹤0.01% |
+88,956
| New | +$113K |
|
2600
Lineage Cell Therapeutics
LCTX
$271M
| $136K | ﹤0.01% |
+85,795
| New | +$145K |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.